Trilogy Capital Inc. bought a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 1,360 shares of the financial services provider’s stock, valued at approximately $280,000.
Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in Marsh & McLennan Companies by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 43,798,034 shares of the financial services provider’s stock worth $8,298,414,000 after purchasing an additional 180,128 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in Marsh & McLennan Companies by 32.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 10,243,245 shares of the financial services provider’s stock worth $1,940,789,000 after purchasing an additional 2,526,701 shares in the last quarter. Ameriprise Financial Inc. grew its stake in Marsh & McLennan Companies by 0.4% in the third quarter. Ameriprise Financial Inc. now owns 8,278,659 shares of the financial services provider’s stock worth $1,575,881,000 after purchasing an additional 31,821 shares in the last quarter. Morgan Stanley grew its stake in Marsh & McLennan Companies by 2.5% in the third quarter. Morgan Stanley now owns 6,145,046 shares of the financial services provider’s stock worth $1,169,403,000 after purchasing an additional 150,655 shares in the last quarter. Finally, Norges Bank bought a new position in Marsh & McLennan Companies in the fourth quarter worth approximately $1,048,077,000. Institutional investors own 87.99% of the company’s stock.
Marsh & McLennan Companies Stock Performance
MMC stock traded down $0.22 during midday trading on Friday, reaching $210.72. The stock had a trading volume of 6,983,166 shares, compared to its average volume of 1,660,440. The stock has a market cap of $103.83 billion, a PE ratio of 26.74, a P/E/G ratio of 2.99 and a beta of 0.93. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.14 and a current ratio of 1.14. The firm has a fifty day simple moving average of $206.87 and a two-hundred day simple moving average of $201.20. Marsh & McLennan Companies, Inc. has a 52-week low of $182.96 and a 52-week high of $216.89.
Insider Buying and Selling at Marsh & McLennan Companies
In other Marsh & McLennan Companies news, SVP Paul Beswick sold 2,169 shares of Marsh & McLennan Companies stock in a transaction dated Friday, May 17th. The stock was sold at an average price of $210.13, for a total transaction of $455,771.97. Following the completion of the transaction, the senior vice president now owns 13,030 shares in the company, valued at approximately $2,737,993.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Marsh & McLennan Companies news, SVP Paul Beswick sold 2,169 shares of Marsh & McLennan Companies stock in a transaction dated Friday, May 17th. The stock was sold at an average price of $210.13, for a total transaction of $455,771.97. Following the completion of the transaction, the senior vice president now owns 13,030 shares in the company, valued at approximately $2,737,993.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Oscar Fanjul sold 6,000 shares of Marsh & McLennan Companies stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $209.01, for a total value of $1,254,060.00. Following the transaction, the director now owns 53,393 shares of the company’s stock, valued at approximately $11,159,670.93. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on the company. Piper Sandler cut Marsh & McLennan Companies from an “overweight” rating to a “neutral” rating and set a $211.00 price objective on the stock. in a research note on Wednesday, April 17th. Keefe, Bruyette & Woods increased their target price on Marsh & McLennan Companies from $185.00 to $188.00 and gave the company an “underperform” rating in a research report on Wednesday, April 10th. Morgan Stanley increased their target price on Marsh & McLennan Companies from $205.00 to $210.00 and gave the company an “equal weight” rating in a research report on Monday, April 15th. Royal Bank of Canada increased their target price on Marsh & McLennan Companies from $210.00 to $228.00 and gave the company a “sector perform” rating in a research report on Friday. Finally, UBS Group increased their target price on Marsh & McLennan Companies from $236.00 to $238.00 and gave the company a “buy” rating in a research report on Monday, April 22nd. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $211.47.
Check Out Our Latest Research Report on Marsh & McLennan Companies
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies, Inc, a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, strategic advisory services, and analytics solutions, and insurance program management services.
Read More
- Five stocks we like better than Marsh & McLennan Companies
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- 3 Stocks to Consider Buying in October
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Using the MarketBeat Stock Split Calculator
- MarketBeat Week in Review – 6/24 – 6/28
Want to see what other hedge funds are holding MMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.